•
Dec 31, 2021

ImmunityBio Q4 2021 Earnings Report

Total Revenue
$390K
Previous year: $21K
+1757.1%
EPS
-$0.23
Previous year: -$0.18
+27.8%
Gross Profit
$390K
Previous year: -$147K
-365.3%
Cash and Equivalents
$181M
Previous year: $34.9M
+418.7%
Free Cash Flow
-$82M
Previous year: -$23.5M
+249.8%
Total Assets
$469M
Previous year: $221M
+111.8%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment